ARCHIVES

FDA Approves Gleevec For First Line Rx Of CML

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

Varmus, Branscomb Win Public Service Award From NSF; NCI Clarifies Plans For Large R01s

June 1, 2001

The First BRCA1 Test Hits The Market; Are Oncologists, Patients Ready?

January 26, 1996

Walter Reed Oncologic Pharmacy Residency Program Has Openings

November 25, 1988

Schmidt Already Working For NIH Despite His Opposition To Kennedy’s New Research Panel

April 5, 1974

FDA Approves Lilly’s Alimta For Metastatic NSCLC

August 27, 2004

Radiologists Dispute Holland On NMR

April 20, 1984